Sveriges mest populära poddar
Oncology Today with Dr Neil Love
Hälsa och motionMedicin

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

52 min•15 maj 2026

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer.

CME information and select publications here.

Fler avsnitt av Oncology Today with Dr Neil Love

Visa alla avsnitt av Oncology Today with Dr Neil Love
HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
•1 tim 39 min
Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
•52 min
Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit
•51 min
EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
•51 min
Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know
•54 min
Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
•58 min
Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
•51 min
For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress
•1 tim 28 min
HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
•52 min
Prostate Cancer — Fifth Annual National General Medical Oncology Summit
•50 min

Oncology Today with Dr Neil Love med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.